Application of arginase-1 and glypican-3 combined examination in differential diagnosis of hepatocellular carcinoma

被引：0
|
作者：
顾春燕 [1 ]
机构：
[1] Dept Pathol,Affil Nantong 3rd Hosp,Nantong Univ
来源：
China Medical Abstracts(Internal Medicine) | 2014年 / 31卷 / 03期
关键词：
HCC; GPC; Application of arginase-1 and glypican-3 combined examination in differential diagnosis of hepatocellular carcinoma;
D O I：
暂无
中图分类号：
R735.7 [肝肿瘤];
学科分类号：
100214 ;
摘要：
Objective To explore the value of arginase-1(Arg-1)and glypican-3(GPC-3)combined examination in the differential diagnosis of hepatocellular carcinoma(HCC),metastatic carcinoma(MC)of liver and intrahepatic cholangiocarcinoma(ICC).Methods From January2005 to December 2011,a total of 54 patients with HCC were selected,including 10 cases with high differentiation,25 cases with moderate differentiation and 19 cases with poor differentiation.At the same time,25 patients with MC of liver and 20 patients with ICC were selected.
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [31] Usefulness of the Novel Oncofetal Antigen Glypican-3 for Diagnosis of Hepatocellular Carcinoma and Melanoma
    Tetsuya Nakatsura
    Yasuharu Nishimura
    BioDrugs, 2005, 19 : 71 - 77
  • [32] Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma
    Nakatsura, T
    Nishimura, Y
    BIODRUGS, 2005, 19 (02) : 71 - 77
  • [33] Immunohistochemical panel of glypican-3, hepatocyte paraffin antigen-1, arginase-1, cytokeratin-19, and human epithelial membrane antigen for the differential diagnosis of liver tumors
    Dongling Zhu
    Dong Kuang
    Sijuan Zou
    Lixing Chen
    Yuanli Zhu
    Xiaohua Zhu
    OncologyandTranslationalMedicine, 2019, 5 (04) : 153 - 161
  • [34] The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection
    Zeyuan Qiang
    Haofeng Zhang
    Shuai Jin
    Cao Yan
    Zhen Li
    Lianyuan Tao
    Haibo Yu
    World Journal of Surgical Oncology, 19
  • [35] Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma
    Krings, Gregor
    Ramachandran, Rageshree
    Jain, Dhanpat
    Wu, Tsung-Teh
    Yeh, Matthew M.
    Torbenson, Michael
    Kakar, Sanjay
    MODERN PATHOLOGY, 2013, 26 (06) : 782 - 791
  • [36] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Wang, Zhen
    Han, Yan-Jiang
    Huang, Shun
    Wang, Meng
    Zhou, Wen-Lan
    Li, Hong-Sheng
    Wang, Quan-Shi
    Wu, Hu-Bing
    AMINO ACIDS, 2018, 50 (02) : 309 - 320
  • [37] The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection
    Qiang, Zeyuan
    Zhang, Haofeng
    Jin, Shuai
    Yan, Cao
    Li, Zhen
    Tao, Lianyuan
    Yu, Haibo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [38] Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
    Filmus, Jorge
    Capurro, Mariana
    FEBS JOURNAL, 2013, 280 (10) : 2471 - 2476
  • [39] Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
    Chen, Min
    Li, Guohua
    Yan, Jian
    Lu, Xiuzhi
    Cui, Jianwei
    Ni, Zhengxian
    Cheng, Weizhong
    Qian, Gengsun
    Zhang, Jing
    Tu, Hong
    CLINICA CHIMICA ACTA, 2013, 423 : 105 - 111
  • [40] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
12345